Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H27NO2 |
Molecular Weight | 325.4446 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=C(OC[C@@H](O)CN[C@H]2CCCC3=C2C=CC=C3)C=CC=C1
InChI
InChIKey=VFDHMSXXELYMRW-ICSRJNTNSA-N
InChI=1S/C21H27NO2/c1-2-16-8-4-6-13-21(16)24-15-18(23)14-22-20-12-7-10-17-9-3-5-11-19(17)20/h3-6,8-9,11,13,18,20,22-23H,2,7,10,12,14-15H2,1H3/t18-,20-/m0/s1
Molecular Formula | C21H27NO2 |
Molecular Weight | 325.4446 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/10344530Curator's Comment: description was created based on several sources, including
https://www.google.com/patents/WO2002009760A3 | https://www.ncbi.nlm.nih.gov/pubmed/8569714 | https://www.ncbi.nlm.nih.gov/pubmed/24175568
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10344530
Curator's Comment: description was created based on several sources, including
https://www.google.com/patents/WO2002009760A3 | https://www.ncbi.nlm.nih.gov/pubmed/8569714 | https://www.ncbi.nlm.nih.gov/pubmed/24175568
SR 59230A is orally active, selective antagonist of the beta-3 adrenergic receptor, SR 59230A has high affinity for the β3 adrenoceptors occurring in human gut that affect the function of human colonic circular smooth muscle.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL246 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10344530 |
49.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22564532
The Goto-Kakizaki (GK) rat aged 3–4 months were treated with SR 59230A. Osmotic pumps (2 ml, 5.0 l/h, 2 weeks duration; Alzet pump, Cupertino, CA, USA) were filled with either SR59230A (0.6 mg/kg * day; Bachem, St. Helen’s Merseyside, UK) or 0.9% NaCl according to manufacturer’s instruction and implanted subcutaneously between the shoulder blades of the rats.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10344530
Isolated rat adipocytes were washed 3 times and incubated in 0.5 ml KRBHA at 37°C (2–5•104 cells) with gentle shaking. SR 59230A at suitable dilutions were added in a 5 μl volume to the cell suspension just before beginning the assay. After 90 min incubation, the reaction was stopped in ice and aliquots taken for enzymatic determination of glycerol, used as the index of lipolysis
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:15:02 GMT 2023
by
admin
on
Sat Dec 16 08:15:02 GMT 2023
|
Record UNII |
YZ574930OD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5311452
Created by
admin on Sat Dec 16 08:15:02 GMT 2023 , Edited by admin on Sat Dec 16 08:15:02 GMT 2023
|
PRIMARY | |||
|
DTXSID6043884
Created by
admin on Sat Dec 16 08:15:02 GMT 2023 , Edited by admin on Sat Dec 16 08:15:02 GMT 2023
|
PRIMARY | |||
|
YZ574930OD
Created by
admin on Sat Dec 16 08:15:02 GMT 2023 , Edited by admin on Sat Dec 16 08:15:02 GMT 2023
|
PRIMARY | |||
|
174689-38-4
Created by
admin on Sat Dec 16 08:15:02 GMT 2023 , Edited by admin on Sat Dec 16 08:15:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
SALT/SOLVATE -> PARENT |
|